Sonia Lopez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 02, 2023
Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.
Journal: Thrombosis and haemostasis
Published: January 25, 2023
A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis.
Journal: Haematologica
Published: March 22, 2022
Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk.
Journal: Thrombosis and haemostasis
Published: March 10, 2022
Expression of microRNAs in human platelet-poor plasma: analysis of the factors affecting their expression and association with proximal genetic variants.
Journal: Epigenetics
Published: June 17, 2020
Identification of a Plasma MicroRNA Profile Associated With Venous Thrombosis.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 13, 2020
Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis.
Journal: PloS one
Published: November 10, 2016
A genome-wide association study in the genetic analysis of idiopathic thrombophilia project suggests sex-specific regulation of mitochondrial DNA levels.
Journal: Mitochondrion
Published: March 10, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026